Search: onr:"swepub:oai:gup.ub.gu.se/294549" >
Ursodeoxycholic aci...
Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.
-
Borges Manna, Luiza (author)
-
Papacleovoulou, Georgia (author)
-
Flaviani, Flavia (author)
-
show more...
-
Pataia, Vanessa (author)
-
Qadri, Asaad (author)
-
Abu-Hayyeh, Shadi (author)
-
McIlvride, Saraid (author)
-
Jansen, Eugene (author)
-
Dixon, Peter (author)
-
Chambers, Jennifer (author)
-
Vazquez-Lopez, Marta (author)
-
Kitaba, Negusse (author)
-
- Marschall, Hanns-Ulrich, 1954 (author)
- Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberg Laboratory,Institute of Medicine, Department of Molecular and Clinical Medicine
-
Godfrey, Keith M (author)
-
Lillycrop, Karen (author)
-
Williamson, Catherine (author)
-
show less...
-
(creator_code:org_t)
- 2020-06-25
- 2020
- English.
-
In: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 10:1
- Related links:
-
https://www.nature.c...
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Perturbations in the intrauterine environment can result in lifelong consequences for metabolic health during postnatal life. Intrahepatic cholestasis of pregnancy (ICP) can predispose offspring to metabolic disease in adulthood, likely due to a combination of the effects of increased bile acids, maternal dyslipidemia and deranged maternal and fetal lipid homeostasis. Whereas ursodeoxycholic acid (UDCA) is a commonly used treatment for ICP, no studies have yet addressed whether it can also prevent the metabolic effects of ICP in the offspring and fetoplacental unit. We therefore analyzed the lipid profile of fetal serum from untreated ICP, UDCA-treated ICP and uncomplicated pregnancies and found that UDCA ameliorates ICP-associated fetal dyslipidemia. We then investigated the effects of UDCA in a mouse model of hypercholanemic pregnancy and showed that it induces hepatoprotective mechanisms in the fetal liver, reduces hepatic fatty acid synthase (Fas) expression and improves glucose tolerance in the adult offspring. Finally, we showed that ICP leads to epigenetic changes in pathways of relevance to the offspring phenotype. We therefore conclude that UDCA can be used as an intervention in pregnancy to reduce features of metabolic disease in the offspring of hypercholanemic mothers.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Borges Manna, Lu ...
-
Papacleovoulou, ...
-
Flaviani, Flavia
-
Pataia, Vanessa
-
Qadri, Asaad
-
Abu-Hayyeh, Shad ...
-
show more...
-
McIlvride, Sarai ...
-
Jansen, Eugene
-
Dixon, Peter
-
Chambers, Jennif ...
-
Vazquez-Lopez, M ...
-
Kitaba, Negusse
-
Marschall, Hanns ...
-
Godfrey, Keith M
-
Lillycrop, Karen
-
Williamson, Cath ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Obstetrics Gynae ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Gastroenterology ...
- Articles in the publication
-
Scientific repor ...
- By the university
-
University of Gothenburg